CD81 and plasma cell myeloma: For instance, while the expression of the TSPAN CD81, also known as TSPAN28, in breast cancer, multiple myeloma, and acute myeloid leukemia is considered a marker for worse prognosis, in patients with gallbladder carcinoma, its expression indicates a favorable outcome [38,39].